FIELD: medicine; pediatrics; otolaryngology; nephrology.
SUBSTANCE: method implies that vaccination against bacterial infection is executed through intramuscular single injection of vaccine "Pneumo 23" dosed 0.5 ml with simultaneous intranasal introduction of immunomodulator "IRS 19" in each nasal duct 2 times a day during 14 days including vaccination day.
EFFECT: reduction of acute respiratory disease rate and underlying disease exacerbation; stable state of specific antipneumococcal immunity on appropriate level.
3 ex, 1 tbl
Authors
Dates
2008-05-27—Published
2005-08-08—Filed